Regular, sustained-release morphine for chronic breathlessness: a multicentre, double-blind, randomised, placebo-controlled trial
Authors:
Abstract
Introduction: Morphine may decrease the intensity of chronic breathlessness but data from a large randomised controlled trial (RCT) are lacking. This first, large, parallel-group trial aimed to test the efficacy and safety of regular, low-dose, sustained-release (SR) morphine compared with placebo for chronic breathlessness.Methods: Multisite (14 inpatient and outpatient cardiorespiratory and palliative care services in Australia), parallel-arm, double-blind RCT. Adults with chronic breathlessness (modified Medical Research Council≥2) were randomised to 20 mg daily oral SR morphine and laxative (intervention) or placebo and placebo laxative (control) for 7 days. Both groups could take ≤6 doses of 2.5 mg, ‘as needed’, immediate-release morphine (≤15 mg/24 hours) as required by the ethics review board. The primary endpoint was change from baseline in intensity ofbreathlessness now(0–100 mm visual analogue scale; two times per day diary) between groups. Secondary endpoints included:worst,bestandaverage breathlessness; unpleasantness ofbreathlessness now, fatigue; quality of life; function; and harms.Results: Analysed by intention-to-treat, 284 participants were randomised to morphine (n=145) or placebo (n=139). There was no difference between arms for the primary endpoint (mean difference −0.15 mm (95% CI −4.59 to 4.29; p=0.95)), nor secondary endpoints. The placebo group used more doses of oral morphine solution during the treatment period (mean 8.7 vs 5.8 doses; p=0.001). The morphine group had more constipation and nausea/vomiting. There were no cases of respiratory depression nor obtundation.Conclusion: No differences were observed between arms for breathlessness, but the intervention arm used less rescue immediate-release morphine.Trial registration number: ACTRN12609000806268.Keywords
Funding Information
- Department of Health, Disability and Ageing
This publication has 35 references indexed in Scilit:
- Opioids for chronic refractory breathlessness: patient predictors of beneficial responseEuropean Respiratory Journal, 2012
- Use of Opioids or Benzodiazepines and Risk of Pneumonia in Older Adults: A Population‐Based Case–Control StudyJournal of the American Geriatrics Society, 2011
- Once-Daily Opioids for Chronic Dyspnea: A Dose Increment and Pharmacovigilance StudyJournal of Pain and Symptom Management, 2011
- Do the Trajectories of Dyspnea Differ in Prevalence and Intensity By Diagnosis at the End of Life? A Consecutive Cohort StudyJournal of Pain and Symptom Management, 2010
- American College of Chest Physicians Consensus Statement on the Management of Dyspnea in Patients With Advanced Lung or Heart DiseaseChest, 2010
- Randomised, double blind, placebo controlled crossover trial of sustained release morphine for the management of refractory dyspnoeaBMJ, 2003
- A systematic review of the use of opioids in the management of dyspnoeaThorax, 2002
- Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary diseaseThorax, 1999
- The Caregiver Quality of Life Index–Cancer (CQOLC) scale: development and validation of an instrument to measure quality of life of the family caregiver of patients with cancerQuality of Life Research, 1999
- The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in OncologyJNCI: Journal of the National Cancer Institute, 1993